Alumis Inc. Common Stock (ALMS)
PHARMACEUTICAL PREPARATIONS
Alumis Inc. Common Stock (ALMS) is listed on Nasdaq, where it has traded since June 28, 2024.
- Listed On
- Nasdaq
- Listed Since
- June 28, 2024
- Employees
- 239
- Market Cap
- $923M
About Alumis Inc. Common Stock
Alumis Inc is a clinical-stage biopharmaceutical company with an initial focus on developing its two Tyrosine Kinase 2 ("TYK2") inhibitors: envudeucitinib ("envu"), an allosteric TYK2 inhibitor for the treatment of PsO and SLE; and A-005, a central nervous system ("CNS") penetrant allosteric TYK2 inhibitor, to offer the therapeutic benefit of TYK2 inhibition within the CNS for a broad range of neuroinflammatory and neurodegenerative diseases.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 191 institutions reported holding ALMS, with 118.1 million shares worth $3.3 billion in aggregate. The largest reported holder was Ayurmaya Capital Management Company, with 15.1 million shares worth $426.0 million. Of the 5 largest holders listed below, 1 opened a new position in ALMS, 2 added shares, 1 reduced its position and 1 held its position unchanged during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| Ayurmaya Capital Management Company | 15,139,707 | $426M | New position |
| BlackRock | 8,218,151 | $231M | Added 14.6% |
| FMR | 6,769,170 | $190M | Added 595.14% |
| Deep Track Capital | 6,348,558 | $179M | Reduced 6.26% |
| Samsara Biocapital | 6,345,219 | $179M | Unchanged |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is ALMS?
Alumis Inc. Common Stock (ALMS) is listed on Nasdaq, where it has traded since June 28, 2024.
Who are the largest institutional holders of ALMS?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of ALMS were Ayurmaya Capital Management Company, BlackRock and FMR.
How many institutions own ALMS?
191 institutions reported a position in ALMS for the quarter ended June 30, 2026, worth $3.3 billion in total.
Did institutions buy or sell ALMS last quarter?
Of the 5 largest reported holders, 1 opened a new position in ALMS, 2 added shares, 1 reduced its position and 1 held its position unchanged during the quarter. Every reported holder and its change is on the SentiSense ownership page for ALMS.
Every reported institutional holder, plus insider and congressional trades in ALMS, on SentiSense.